ATE486878T1 - Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin - Google Patents

Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin

Info

Publication number
ATE486878T1
ATE486878T1 AT05777861T AT05777861T ATE486878T1 AT E486878 T1 ATE486878 T1 AT E486878T1 AT 05777861 T AT05777861 T AT 05777861T AT 05777861 T AT05777861 T AT 05777861T AT E486878 T1 ATE486878 T1 AT E486878T1
Authority
AT
Austria
Prior art keywords
benzothienopyridines
kinesin inhibitors
compounds
kinesin
inhibitors
Prior art date
Application number
AT05777861T
Other languages
English (en)
Inventor
Matthias Vennemann
Thomas Baer
Gudrun Groegor
Juergen Braunger
Petra Gimmnich
Thomas Maier
Heike Rothfels
Original Assignee
4Sc Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4Sc Ag filed Critical 4Sc Ag
Application granted granted Critical
Publication of ATE486878T1 publication Critical patent/ATE486878T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
AT05777861T 2004-08-18 2005-08-17 Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin ATE486878T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04103958 2004-08-18
EP04104175 2004-08-31
PCT/EP2005/054054 WO2006018435A1 (en) 2004-08-18 2005-08-17 Benzothienopyridines for use as inhibitors of eg5 kinesin

Publications (1)

Publication Number Publication Date
ATE486878T1 true ATE486878T1 (de) 2010-11-15

Family

ID=35285513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05777861T ATE486878T1 (de) 2004-08-18 2005-08-17 Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin

Country Status (8)

Country Link
US (2) US7718665B2 (de)
EP (1) EP1781667B1 (de)
JP (1) JP2008509971A (de)
AT (1) ATE486878T1 (de)
AU (1) AU2005273867B2 (de)
CA (1) CA2576619A1 (de)
DE (1) DE602005024572D1 (de)
WO (1) WO2006018435A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005273867B2 (en) 2004-08-18 2010-12-23 4Sc Ag Benzothienopyridines for use as inhibitors of Eg5 kinesin
AU2006208709A1 (en) * 2005-01-27 2006-08-03 4Sc Ag Novel indolopyridines , benzofuranopyridines and benzothienopyridines
WO2006079644A1 (en) * 2005-01-28 2006-08-03 Nycomed Gmbh Indolopyridines, benzofuranopyridines and benzothienopyridines
US20090246169A1 (en) * 2006-02-22 2009-10-01 Matthias Vennemann Indolopyridines as eg5 kinesin modulators
WO2007096393A1 (en) * 2006-02-22 2007-08-30 4Sc Ag Indolopyridines as eg5 kinesin modulators
CA2658223A1 (en) * 2006-07-13 2008-01-17 4Sc Ag Benzopyranopyrazoles
CA2697246A1 (en) * 2007-08-22 2009-02-26 4Sc Ag Indolopyridines as inhibitors of the kinesin spindle protein (eg5)
EP2033962A1 (de) * 2007-08-22 2009-03-11 4Sc Ag Tetrazyclische Indolopyridinderivate als EG5-Hemmer
US20130210733A1 (en) 2010-06-17 2013-08-15 Cytokinetics, Inc. Methods of treating lung disease
KR101390616B1 (ko) 2012-03-28 2014-04-29 주식회사 두산 신규 화합물 및 이를 포함하는 유기 전계 발광 소자
CN110464722B (zh) * 2019-06-06 2023-05-23 暨南大学 一类小分子化合物或其药学上可接受的盐在制备抗肿瘤转移药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357122A3 (de) * 1988-08-29 1991-10-23 Duphar International Research B.V Verwendung von Beta-Carbolinen und deren bio-isosterischen Benzofuran- und Benzothiophenanalogen zur Herstellung eines Arzneimittels mit cytostatischer Wirkung
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
US6217104B1 (en) * 1999-06-16 2001-04-17 Cts Fahrzeug Dachsysteme Gmbh Retractable hard top module
US6890933B1 (en) * 2000-02-24 2005-05-10 President And Fellows Of Harvard College Kinesin inhibitors
ES2267831T3 (es) 2000-10-03 2007-03-16 Lilly Icos Llc Derivados de piridoindol condensado.
US7067315B2 (en) * 2001-05-22 2006-06-27 President And Fellows Of Harvard College Identification of anti-protozoal agents
CA2460939C (en) 2001-09-19 2008-07-29 Pharmacia Corporation Substituted pyrazolyl compounds for the treatment of inflammation
AU2003247891A1 (en) 2002-07-08 2004-01-23 Merck & Co., Inc. Mitotic kinesin binding site
US7022850B2 (en) 2003-05-22 2006-04-04 Bristol-Myers Squibb Co. Bicyclicpyrimidones and their use to treat diseases
JP4580932B2 (ja) 2003-06-12 2010-11-17 メルク・シャープ・エンド・ドーム・コーポレイション 有糸分裂キネシン阻害剤のプロドラッグ
AU2005273867B2 (en) 2004-08-18 2010-12-23 4Sc Ag Benzothienopyridines for use as inhibitors of Eg5 kinesin
AU2006212863A1 (en) 2005-02-10 2006-08-17 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
US20090246169A1 (en) 2006-02-22 2009-10-01 Matthias Vennemann Indolopyridines as eg5 kinesin modulators
WO2007096393A1 (en) 2006-02-22 2007-08-30 4Sc Ag Indolopyridines as eg5 kinesin modulators
EP2035426A1 (de) 2006-06-14 2009-03-18 4Sc Ag Pyrazolopyrimidone
CA2658223A1 (en) 2006-07-13 2008-01-17 4Sc Ag Benzopyranopyrazoles

Also Published As

Publication number Publication date
AU2005273867B2 (en) 2010-12-23
US7718665B2 (en) 2010-05-18
JP2008509971A (ja) 2008-04-03
DE602005024572D1 (de) 2010-12-16
WO2006018435A1 (en) 2006-02-23
US20100183550A1 (en) 2010-07-22
EP1781667A1 (de) 2007-05-09
CA2576619A1 (en) 2006-02-23
US20070232596A1 (en) 2007-10-04
EP1781667B1 (de) 2010-11-03
AU2005273867A1 (en) 2006-02-23
US8044065B2 (en) 2011-10-25

Similar Documents

Publication Publication Date Title
ATE486878T1 (de) Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
NL301145I2 (nl) Tirbanibulin
MX2008010801A (es) Indolopiridinas como moduladores de quinesina eg5.
EA200602157A1 (ru) Новые производные тетрагидропиридотиофена
EA200601568A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
ATE471324T1 (de) Triazolophthalazine
ATE395336T1 (de) Chinolinderivate zur verwendung als inhibitoren von mycobakterien
NO20073921L (no) Triazoloftalaziner
EA200801852A1 (ru) Индолопиридины в качестве модуляторов кинезина eg5
ATE477249T1 (de) Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
ATE445402T1 (de) Neue verwendung von pde5-hemmern
ATE397000T1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
DE602005010821D1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
BRPI0615141A2 (pt) inibidores pentacìclicos de quinase
NO20064491L (no) Nye difluomtoksysubstituee hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer
EA200701626A1 (ru) Новые 6-пиридилфенантридины
DE602006018725D1 (de) Amidin-derivate zur verwendung in der vorbeugung oder behandlung von glaukom
ATE508130T1 (de) 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
ATE423772T1 (de) Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
DE60321248D1 (de) Verwendung von pollen-isolierten proteinen zur inhibierung der aktivität des anthrax-toxins
ATE490767T1 (de) Amidin-derivate zur verwendung in der vorbeugung oder behandlung von glaukom

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties